FDA rejects motion sickness drug from Defender Pharma

Foghorn Ther­a­peu­tics said Wednes­day morn­ing that it was stop­ping fur­ther work on an ex­per­i­men­tal drug for a rare ad­vanced eye can­cer that has spread to

The FDA announced a voluntary recall of an over-the-counter glucose support supplement for the presence of metformin and glyburide. Over the past two decades, the

The US House of Rep­re­sen­ta­tives on Mon­day evening passed the Biose­cure Act with broad bi­par­ti­san sup­port, ad­vanc­ing a con­tro­ver­sial bill that could up­end many drug­mak­ers’